Znaczenie stosunku liczby neutrofili do limfocytów jako czynnika predykcyjnego dysfunkcji rozkurczowej lewej komory serca u chorych z przewlekłą chorobą nerek by Gromadziński, Leszek et al.
1www.journals.viamedica.pl/folia_cardiologica
Folia Cardiologica 2018 
tom 13, nr 1, strony 1–8 
DOI: 10.5603/FC.2018.0001 
Copyright © 2017 Via Medica
ISSN 2353–7752
PRACA ORYGINALNA
Address for correspondence: dr hab. n. med. Leszek Gromadziński, Wydział Nauk Medycznych, Uniwersytet Warmińsko-Mazurski w Olsztynie,  
ul. Warszawska 30, 10–082 Olsztyn, Poland, phone +48 89 524 5 389, e-mail: lgol@op.pl
The role of neutrophil to lymphocyte ratio  
as a predictor of left ventricular diastolic dysfunction  
in chronic kidney disease patients
Znaczenie stosunku liczby neutrofili do limfocytów jako czynnika predykcyjnego 
dysfunkcji rozkurczowej lewej komory serca u chorych z przewlekłą chorobą nerek
Leszek Gromadziński1, 2, Beata Januszko-Giergielewicz1, 3, Rakesh Jalali1, 4, Tomasz Arłukowicz1, 5, Piotr Pruszczyk6 
1Faculty of Medical Sciences, University of Warmia and Mazury, Olsztyn, Poland 
2Department of Cardiology and Internal Medicine, University Clinical Hospital in Olsztyn, Olsztyn, Poland 
3Department of Transplantation, Provincial Specialist Hospital in Olsztyn, Olsztyn, Poland 
4Emergency Medicine Department, Provincial Specialist Hospital in Olsztyn, Poland 
5Department of Gastroenterology, Provincial Specialist Hospital in Olsztyn, Olsztyn, Poland 
6Department of Internal Medicine and Cardiology, Medical University of Warsaw, Poland
Abstract
Introduction. Left ventricular diastolic dysfunction (LVDD) occurs very often in patients with chronic kidney disease 
(CKD). The neutrophil to lymphocyte ratio (NLR) is a novel inflammatory marker, which has a predictive value in different 
cardiovascular diseases. We have evaluated the association between NLR and LVDD among CKD patients.
Material and methods. The study group consisted of 54 ambulatory patients with CKD at stages 3–5 with preserved 
left ventricular (LV) systolic function. The CKD patients were divided into two groups, depending on the results of mitral 
early diastolic velocity EmLV: the group with LV diastolic dysfunction LVDD(+), when EmLV < 8 cm/s, and the group 
with normal LV diastolic function LVDD(–), when EmLV ≥ 8 cm/s. NLR was calculated as the ratio of the neutrophil and 
lymphocyte counts.
Results. Patients in LVDD(+) group had significantly higher values of NLR when compared to patients in LVDD(–) group 
(2.51 [1.12–9.82] vs. 1.75 [0.99–3.64], p = 0.007). NLR negatively correlated with EmLV (r = –0.311, p = 0.021), while 
positively with N-terminal B-type natriuretic propeptide (r = 0.292, p = 0.037). Among the examined parameters, NLR 
was an independent predictive factor for LVDD with odds ratio 3.14 (95% confidence interval [CI] 1.05–9.42), p = 0.034. 
The area under the receiver operating characteristics curve for NLR was 0.714 (95% CI 0.575–0.828), p = 0.003, and 
using a cut point of 1.77, the NLR predicted LVDD with a sensitivity of 92.3% and specificity of 53.6%.
Conclusions. This study suggests that elevated neutrophil to lymphocyte ratio as an indicator of inflammation seems to 
be a useful marker of LVDD in CKD patients.
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biplane modified Simpson’s method. Left ventricular mass 
(LVM) was calculated with the formula recommended by the 
American Society of Echocardiography (ASE), modified by 
Devereux [10]. The obtained results of LVM were indexed by 
the body surface area of the patient and presented as the 
left ventricular mass index (LVMI). The mitral inflow early 
diastolic wave (E), late diastolic wave (A), E/A ratio, decele-
ration time (DT) of the E wave, were measured on pulsed 
wave Doppler echocardiography in a four chamber view [9].
Tissue Doppler echocardiography  
examination
Using pulsed wave tissue Doppler echocardiography, sys-
tolic and diastolic velocities were measured by placing the 
Doppler gate on the lateral mitral annulus at the poster ior 
leaflet of the mitral valve. The following parameters were 
measured: mitral annular systolic velocity (SmLV), early 
diastolic velocity (EmLV), and late diastolic velocity (AmLV) 
of the lateral part of the examined annulus [11]. The ratio 
of early transmitral velocity (E) to the mitral annular early 
diastolic velocity (EmLV) was used as an approximation 
of mean left atrial pressure (E/EmLV). All the parameters 
were calculated as the mean of measurements taken in 
three consecutive cardiac cycles. Diastolic dysfunction of 
left ventricular was defined as EmLV < 8 cm/s [12].
The CKD patients were divided into two groups depen-
ding on the results of EmLV: LVDD(+) group with LV diastolic 
dysfunction when EmLV < 8 cm/s, and LVDD(–) group with 
normal LV diastolic function, when EmLV ≥ 8 cm/s.
Biochemical tests
Blood samples of all the individuals were collected on the 
day of echocardiographic examination and the following 
laboratory parameters were measured for all the patients: 
serum creatinine concentration, estimated glomerular 
filtration rate (eGFR) evaluated by the modified MDRD 
(Modification of diet in Renal Disease) formula, as well as 
the serum levels of urea, phosphorus (P), calcium (Ca), 
C-reactive protein (CRP), parathormone (PTH) and N-termi-
nal B-type natriuretic propeptide (NT-proBNP) levels were 
calculated by immunoassay with the Stratus® CS Acute 
CareTM Siemens.
Additionally, blood samples were taken and the follow-
ing parameters were recorded: red cell distribution width 
(RDW), mean corpuscular volume (MCV), haemoglobin 
concentration (Hb), platelets (PLT), mean platelet volume 
(MPV), neutrophils and lymphocytes count. NLR was calcu-
lated as the ratio of the neutrophil and lymphocyte counts. 
The platelet-to-lymphocyte ratio (PLR) was calculated as 
the platelet count divided by the lymphocyte count.
Statistical analysis
The values of parameters with normal distribution were 
presented as a mean ± standard deviation, whereas values 
with non-normal distributions were expressed as a median 
Introduction
Chronic kidney disease (CKD) is a major public health 
problem, affecting 10–15% of the adult general population. 
Cardiovascular diseases are the most common cause of 
mortality in patients with CKD [1, 2]. Heart failure with 
preserved ejection fraction (HFpEF), characterised by 
normal left ventricular ejection fraction and abnormalities 
of ventricular filling, including decreased diastolic distensi-
bility and impaired relaxation is independently associated 
with morbidity and mortality in CKD patients [3–5]. Left 
ventricular hypertrophy due to arterial hypertension and 
chronic anaemia, either calcium phosphate disturbances 
or hypervolemia are important factors for developing left 
ventricular diastolic dysfunction (LVDD) in this patients’ 
population [6, 7]. The previous studies have shown that 
persistent inflammation, which occurs in CKD, may lead 
to development of LVDD [8]. In recent years, neutrophil to 
lymphocyte ratio (NLR) was proposed as a novel marker 
to determine inflammation in cardiac and non-cardiac 
disorders and it (is readily available in the routine blood 
analysis. Although the relationship between NLR and al-
most all cardiovascular diseases have been investigated, 
the importance of NLR in diastolic dysfunction in CKD pa-
tients remains unclear. In our study, we have evaluated the 
association between NLR and LVDD among CKD patients.
Material and methods
The study group consisted of 54 ambulatory patients with 
CKD at stages 3–5, with preserved left ventricular (LV) sys-
tolic function defined at echocardiography by an LV ejection 
fraction (LVEF) > 50%, with lack of regional wall motion 
abnormalities and with sinus rhythm. The exclusion crite-
ria comprised as follows: LV systolic dysfunction, previous 
myocardial infarction, cardiomyopathy, significant valvular 
heart diseases, cancer, active chronic inflammation or 
acute infectious diseases within four weeks.
Echocardiography
The echocardiographic evaluations of all the subjects were 
performed by a single, experienced cardiologist who was 
not informed of the clinical or laboratory findings of the pa-
tients. Standard echocardiography was performed in all the 
patients using a GE 6S device with 2.5–3.5 MHz transducer. 
M-mode echocardiography and a quantitative analysis were 
conducted using parasternal long axis images based on data 
provided by the American Society of Echocardiography [9]. 
The left ventricular end-diastolic dimension (LVEDD), right 
ventricular end-diastolic dimension (RVEDD), left atrial 
dimension (LAD), interventricular septal diastolic diameter 
(IVSd), left ventricular posterior wall dimension at diastole 
(LVPWd), were obtained using M-mode echocardiographic 
tracings under the guide of 2D imaging. The left ventricular 
ejection fraction (LVEF) was calculated according to the 
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and range. Normal distribution of continuous variables 
was tested using Kolmogorov-Smirnov’s and Shapiro-Wilk’s 
tests. Continuous variables with normal distribution were 
compared using Student’s t-test and those without normal 
distribution were compared using Mann-Whitney’s U test. 
The chi-square test was used to compare the categorical 
variables. The correlation analyses were made using Spear-
man’s test. The receiver operating characteristic (ROC) anal-
ysis curves served to determine the optimal cut-off points of 
the NLR in association with LV diastolic dysfunction.
The multivariate logistic regression analysis was per-
formed to assess the independent predictors of LV diastolic 
dysfunction and the results were shown as odds ratio 
(OR) with 95% confidence intervals (95% Cl). A value of 
p < 0.05 was considered statistically significant. Statistical 
analyses were conducted using Statistica 6 software and 
MedCalc (version 12.5.0).
All the patients consented in writing for the inclusion 
in the research. The study protocol was approved by the 
bioethics committee.
Results
Clinical and echocardiographic  
characteristics
The present study included 54 patients (25 males and 
29 females aged 67.9 ± 12) with CKD at stages 3–5. The 
patients were divided into two groups depending on the 
results of EmLV: LVDD(+) group with LV diastolic dysfunction 
when EmLV < 8 cm/s, and LVDD(–) group with normal LV 
diastolic function, when EmLV ≥ 8 cm/s. Distribution of 
the baseline characteristics and echocardiographic data 
obtained by statistical analyses among the groups is sum-
marised in Table 1. The mean age was 68.7 ± 12.2 in the 
group of 26 CKD patients with LVDD while it was 67.1 ± 12.3 
in the group of 28 CKD patients without LVDD (p = 0.636). 
The patients of both groups did not differ in gender, pre-
sence of arterial hypertension and diabetes. There was no 
statistically significant difference between two groups by 
the means of body mass index (BMI). Patients with LVDD, 
as compared to patients without LVDD, were characterised 
by more advanced stage of CKD (Table 1).
In echocardiography, patients with LVDD(+), as com-
pared to patients with LVDD(–)were characterised by 
significantly higher values of LVMI, IVSd, LVPWd, DT, 
E/EmLV ratios, and lower values of E, EmLV, E/A ratios 
and Em/AmLV ratios. No differences were noted for the 
following parameters: LVEDD, RVEDD, LAD, LVEF, LVFS, A, 
SmLV and AmLV.
Laboratory data
Patients with LVDD, as compared to patients without LVDD, 
were characterised by significantly lower serum Ca levels 
and higher CRP levels, whereas serum of creatinine, urea, 
P and NT-proBNP were of borderline significance. There was 
no statistically significant difference between two groups 
in serum of parathormone levels.
Patients with LVDD had significantly higher NLR values 
when compared to the group of patients without LVDD 
(2.51 [1.12–9.82) vs. 1.75 [0.99–3.64], p = 0.007). Other 
parameters of blood count analysis were also evaluated 
and are presented in Table 2. RDW-SD, MCV, Hb, PLT, MPV, 
neutrophil and the mean value of platelet to lymphocyte 
ratio (PRL) did not differ significantly between two groups, 
only lymphocyte value was lower in LVDD(+) group com-
pared with LVDD(–) group.
Spearman’s correlation analyses showed that NLR was 
negatively correlated with echocardiographic parameters 
of diastolic dysfunction, EmLV (r = –0.311, p = 0.021) and 
positively correlated with NT-proBNP (r = 0.292, p = 0.037) 
and parathormone (r = 0.284, p = 0.038).
In order to determine independent parameters indica-
ting LV diastolic dysfunction in CKD patients, univariate 
and multivariate logistic regression analyses were per-
formed. Into multivariable analysis, only parameters with 
p < 0.1 in univariate logistic regression were included. 
Among the examined parameters, the NLR was found to 
be an independent predictive factor for LV diastolic dys-
function, except BMI and Ca (Table 3).
In the receiver operating characteristics (ROC) curve 
analysis, a level of NLR > 1.77 predicted LV diastolic 
dysfunction in CKD patients with 92.3% sensitivity and 
53.6% specificity. The area under the ROC curve for NLR 
was 0.714 (95% CI 0.575–0.828, p = 0.003) (Figure 1).
Discussion
In our study, we have found that NLR level was increased in 
CKD patients with LV diastolic dysfunction compared with 
CKD patients without diastolic dysfunction, and was an 
independent predictive factor for LV diastolic dysfunction 
with OR 3.14, 95% CI 1.05–9.42, p = 0.034. Furthermore, 
the NLR showed negative correlation with EmLV, and posi-
tive correlation with NT-proBNP and PTH plasma levels. 
Moreover, using a cut point of 1.77, the NLR predicted 
LV diastolic dysfunction with a sensitivity of 92.3% and 
specificity of 53.6%.
Numerous studies have demonstrated that an in-
creased neutrophil count might reflect an inflammation 
and that lymphopenia is an indicator of physiologic stress, 
which may lead to the cortisol secretion. The NLR have 
been associated with poor outcomes in patients with 
cardiovascular disease. However, the NLR has proved 
to predict mortality more accurately than other absolute 
neutrophil or lymphocyte counts [13, 14]. To the best of our 
knowledge, this study is the first research which showed 
the importance of NLR levels in detection of diastolic 
dysfunction among patients with CKD.
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Table 1. Baseline characteristics, biochemical and echocardiographic findings of both groups





Age 68.7 ± 12.2 67.1 ± 12.3 0.636
Gender [M/F] 15/11 10/18 0.111
BMI [kg/m2] 28.1 30.8 0.072
Hypertension, n [%] 21 (81) 23 (82) 0.896
Stage 3 CKD, n [%] 12 (46) 24 (85) 0.002
Stage 4 CKD, n [%] 10 (38) 3 (11) 0.017
Stage 5 CKD, n [%] 4 (15) 1 (4) 0.134
Diabetes, n [%] 5 (19) 7 (25) 0.610
Creatinine [mg/dL] 2.1 (1.2–6.3) 1.5 (1.0–4.3) 0.055
eGFR [mL/min/1.73 m2] 30.1 ± 14.5 37.2 ± 12.6 0.059
Urea [mg/dL] 75 (30–160) 59 (20–137) 0.057
P [mg/dL] 3.8 (2.7–7.8) 3.5 (2.3–5.9) 0.062
Ca [mg/dL] 8.7 ± 0.8 9.3 ± 0.8 0.019
CRP [mg/mL] 4.1 (1.0–36) 3.0 (1.0–30) 0.045
Log PTH [pg/mL] 1.99 ± 0.32 1.88 ± 0.31 0.193
Log NT-proBNP [pg/mL] 2.52 ± 0.47 2.28 ± 0.39 0.053
LVEDD [cm] 4.8 ± 0.6 4.6 ± 0.4 0.131
RVEDD [cm] 2.8 ± 0.2 2.7 ± 0.2 0.185
LAD [cm] 4.3 ± 0.5 4.0 ± 0.5 0.125
IVSd [cm] 1.2 (1.0–1.5) 1.1 (0.9–1.5) 0.010
LVPWd [cm] 1.2 (0.9–1.4) 1.1 (0.9–1.5) 0.034
LVEF [%] 58.1 ± 5.4 59.9 ± 5.5 0.218
LVMI [g/m2] 106.5 (60.2–198) 89.0 (57.9–137.5) 0.006
LVFS [%] 30.1 ± 4.1 31.0 ± 3.4 0.365
E [cm/s] 55 ± 15 72 ± 19 0.001
A [cm/s] 80 (55–141) 74 (50–118) 0.585
DT [ms] 250 ± 58 221 ± 44 0.043
E/A ratio 0.62 (0.42–1.24) 0.9 (0.56–1.9) < 0.001
SmLV [cm/s] 7 (5–14) 8 (5–11) 0.096
EmLV [cm/s] 6 (3–7) 9 (8–14) < 0.001
AmLV [cm/s] 10.4 ± 2.4 9.8 ± 2.6 0.383
EmLV/AmLV ratio 0.54 (0.35–1.0) 0.95 (0.56–2.25) < 0.001
E/EmLV ratio 9.5 ± 2.2 7.8 ± 2.3 0.009
NLR 2.51 (1.12–9.82) 1.75 (0.99–3.64) 0.007
LVDD(+) — group with left ventricular diastolic dysfunction; LVDD(–) — group without left ventricular diastolic dysfunction; M — male; F — female; BMI — body mass index; CKD — chronic kidney disease;  
eGFR — estimated glomerular filtration rate; P — serum levels of phosphorus; Ca — serum levels of calcium; CRP — C-reactive protein; log PTH — logarithm of parathormone; log NT-proBNP — logarithm  
of N-terminal pro-brain natriuretic peptide; LVEDD — left ventricular end-diastolic dimension; RVEDD — right ventricular end-diastolic dimension; LAD — left atrial diastolic dimension; IVSd — interventricular 
septal diastolic diameter; LVPWd — left ventricular posterior wall dimension at diastole; LVEF — left ventricular ejection fraction; LVMI — left ventricular mass index; LVFS — left ventricular fractional 
shortening; E — early transmitral velocity; A — late transmitral velocity; DT — deceleration time; E/A ratio — ratio of early transmitral velocity to late transmitral velocity; SmLV — mitral annular 
systolic velocity; EmLV — mitral annular early diastolic velocity; AmLV — mitral annular late diastolic velocity; EmLV/AmLV — ratio of mitral annular early diastolic velocity to mitral annular late diastolic velocity; 
E/EmLV ratio — ratio of early transmitral velocity to mitral annular early diastolic velocity; NLR — neutrophil to lymphocyte ratio
The previous studies have reported that the NLR has 
emerged as a new marker in different diseases, inclu-
ding cardiac disorders. The prognostic value of NLR has 
demonstrated in pulmonary embolism, coronary artery 
disease, myocardial infarction, stroke, and heart failure 
(HF) [15–19]. Beyond atherosclerotic disorders, NLR was 
also found to be associated with idiopathic dilated cardio-
myopathy, mitral annular calcification, infective endocar-
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ditis and atrial septal aneurysm [20–23]. Moreover, other 
studies have found that NLR was increased in non-dippers 
with arterial hypertension when compared with dipper and 
normotensive subjects. Additionally, NLR significantly cor-
related with blood pressure variation rate, and itwas found 
to be an independent predictor of blood pressure variabi-
lity [24]. It is widely suggested that inflammation plays an 
important role in the progression and severity of cardiac 
diseases. The functional and structural impairment of 
heart and development of cardiovascular diseases may be 
associated with increased levels of inflammatory markers, 
which shows the balance between degenerative and con-
trolled inflammatory responses. Inflammatory processes 
play a pivotal role in the development of HF and CKD [25, 
26]. White blood cells and their subtypes release many 
inflammatory cytokines, such as tumour necrosis factor α 
(TNF-α), interleukin 6 (IL-6), and CRP as a result of in-
flammatory stimulus. These pro-inflammatory cytokines 
have destructive effect on the myocardium, resulting in 
decreased LV function and occur heart failure [27, 28]. 
This situation may happenin the developing HFpEF, where 
the crucial role is played by the diastolic dysfunction of 
the left ventricle. The previous studies have shown that 
higher levels of pro-inflammatory cytokines may lead to 
myocardial remodelling [29]. Karagöz A et al. [30] presen-
ted that hypertension patients with diastolic dysfunction 
had higher values of NLR compared to subjects without 
diastolic dysfunction. Moreover, when grades of diastolic 
dysfunction were evaluated, patients with third grade of 
diastolic dysfunction had the highest NLR values, while 
patients with first grade had the lowest, supporting an 
association between diastolic dysfunction and NLR in 
hypertension patients [30]. In our study, we have showed 
that CKD patients with LV diastolic dysfunction had sig-
nificantly higher NLR value compared with CKD patients 
without LV diastolic dysfunction. Furthermore, the NLR 
Table 2. Evaluation of other haematological parameters





RDW-SD [%] 14.1 (12.9–19.5) 13.7 (12.7–16.2) 0.104
MCV 89.9 ± 4.8 89.6 ± 4.5 0.823
Hb 12.4 ± 1.5 12.4 ± 1.8 0.901
PLT 198 (89–484) 213 (126–453) 0.446
MPV 11.1 ± 1.1 11.1 ± 0.9 0.975
Neutrophil 4.07 ± 0.92 3.94 ± 1.21 0.666
Lymphocyte 1.62 ± 0.55 2.14 ± 0.78 0.007
PLR 122 (64–322) 109 (61–242) 0.077
NLR 2.51 (1.12–9.82) 1.75 (0.99–3.64) 0.007
LVDD(+) — group with left ventricular diastolic dysfunction; LVDD (–) — group without left ventricu-
lar diastolic dysfunction; RDW-SD — red cell distribution width-standard deviation; MCV — mean 
corpuscular volume; Hb — haemoglobin concentration; PLT — platelets; MPV — mean platelet 
volume; PLR — platelet to lymphocyte ratio; NLR — neutrophil to lymphocyte ratio
Table 3. Biochemical parameters for the prediction of left ventricle diastolic dysfunction (EmLV < 8 cm/s). Univariate and multivariate 
logistic regression analysis
Parameter Univariate analysis Multivariate analysis
OR 95% CI p OR 95% CI p
Creatinine [mg/dL] 2.02 1.04–3.95 0.033 1.27 0.26–6.26 0.760
Urea [mg/dL] 1.02 1.00–1.04 0.035 1.02 0.97–1.06 0.388
Ca [mg/dL] 0.41 0.18–0.92 0.028 0.30 0.10–0.89 0.025
Log NT-proBNP [pg/mL] 3.70 0.91–14.99 0.059 0.65 0.08–4.88 0.674
BMI [kg/m2] 0.90 0.81–1.01 0.078 0.80 0.67–0.96 0.016
NLR 2.39 1.13–5.04 0.018 3.15 1.05–9.42 0.035
CI — confidence interval; Ca — serum levels of calcium; BMI — body mass index; Log NT-proBNP — logarithm of N-terminal B-type natriuretic propeptide; NLR — neutrophil to lymphocyte ratio; OR — odds ratio
Figure 1. The receiver operating characteristic curves for neu-
trophil to lymphocyte ratio (NLR) to predict left ventricle diastolic 
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it is unclear whether the results can be applied to other po-
pulations. Our analyses are based on single measurements 
of blood test marker. In addition, we could not study the 
other inflammatory markers, such as fibrinogen, TNF-α, and 
interleukins. The presence of diabetes mellitus should be 
an exclusion criterion, however as the amount of diabetes 
in both groups was similar, it was decided not to exclude 
them from the study, but it obviously limited our study.
Conclusion
This study showed, that NLR seems to be a useful marker of 
LVDD in CKD patients. NLR may be used as an additional, 
simple, reliable and economic marker of LV diastolic dys-
function. Further prospective studies, with larger sample 
sizes are needed to shed the light on the mechanism 
underlying this association.
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was an independent predictive factor for LV diastolic 
dysfunction in this population. In our research, CRP level 
was higher in group with diastolic dysfunction compared 
with group without diastolic dysfunction. Interestingly, 
CRP level did not reach statistical significance in univar-
iate logistic regression analysis for the diagnosis of LV 
diastolic dysfunction in CKD patients. Additionally, PLR 
did not differ between both groups. In summary, among 
our inflammatory parameters, the best predictive value 
indicating LV diastolic dysfunction in patients with CKD 
was NLR only. We know, that patients with LVDD had more 
advanced CKD than patients without diastolic dysfunction 
(46% patients were in third stage and 54% in fourth and 
fifth stages of CKD in LVDD group compared to group 
without LVDD, where were 85% in third stage  and only 
15% in fourth and fifth stages). However, the serum cre-
atinine concentration in both groups was not statistically 
significant, but only of borderline significance. We believe, 
that our study may inspire further trials to investigate the 
mechanism involved in the development of LV diastolic 
dysfunction in CKD patients and evaluate the possible 
role of inflammation in this process.
Study limitations
The present study has several limitations. It was a sin-
gle-centre study, based on a small number of patients, so 
Streszczenie
Wstęp. Dysfunkcja rozkurczowa lewej komory serca (LVDD) często rozwija się u osób z przewlekłą chorobą nerek (CKD). 
Stosunek liczby neutrofilów do liczby limfocytów (NLR) jest nowym markerem zapalnym, który uznaje się także za czynnik 
predykcyjny wielu chorób układu sercowo-naczyniowego. W opisanym badaniu oceniano związek między NLR a LVDD 
wśród chorych na CKD.
Materiał i metody. Do badania włączono 54 chorych w 3.–5. stadium CKD z zachowaną frakcją wyrzutową lewej komory. 
Pacjentów podzielono na dwie grupy zależnie od wartości prędkości wczesnej fazy rozkurczowej pierścienia mitralnego 
(EmLV) — grupę z dysfunkcją rozkurczową lewej komory LVDD(+), kiedy EmLV wynosi poniżej 8 cm/s i grupę z prawidłową 
funkcją rozkurczową lewej komory LVDD(–), kiedy EmLV wynosi 8 cm/s lub więcej.
Wyniki. Pacjęnci z grupy LVDD(+) charakteryzowali się istotnie wyższymi wartościami NLR niż chorzy z grupy LVDD(–), 
odpowiednio (2,51 [1,12–9,82] v. 1,75 [0,99–3,64]; p = 0,007). Stosunek liczby neutrofilów do liczby limfocytów kore-
lował ujemnie z EmLV (r = –0,311; p = 0,021) oraz dodatnio ze stężeniem N-końcowego fragmentu propetydu natriure-
tycznego typu B (r = 0,292, p = 0,037). Spośród badanych parametrów NLR było niezależnym czynnikiem predykcyjnym 
LVDD z ilorazem szans 3,14 (95-proc. przedział ufności [CI] 1,05–9,42); p = 0,034. Pole powierzchni pod krzywą (ROC) 
dla NLR w rozpoznaniu LVDD wynosiło 0,714 (95% CI 0,575–0,828; p = 0,003), a wartość NLR 1,77 uzyskana w analizie 
ROC charakteryzowała się 92,3-procentową czułością i 53,6-procentową swoistością w rozpoznaniu LVDD.
Wnioski. Wyniki badania sugerują, że podwyższony NLR jako parametr stanu zapalnego może być użytecznym marke-
rem LVDD u chorych na CKD.
Słowa kluczowe: stosunek neutrofilów do limfocytów, dysfunkcja rozkurczowa, przewlekła choroba nerek
Folia Cardiologica 2018; 13, 1: 1–8
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